Sign up to save your podcasts
Or
Share Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org.
Show reference:
https://www.neurology.org/doi/10.1212/WNL.0000000000209745
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org.
Show reference:
https://www.neurology.org/doi/10.1212/WNL.0000000000209745
More shows like Neurology Minute
View all
JAMA Editors' Summary
130 Listeners
Neurology® Podcast
289 Listeners
NEJM This Week
325 Listeners
Practical Neurology Podcast
45 Listeners
JAMA Clinical Reviews
492 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
87 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
185 Listeners
Navigating Neuropsychology
340 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
366 Listeners
Continuum Audio
77 Listeners